Logo

American Heart Association

  25
  0


Final ID: Sun1003

A recombinant protein oxygen carrier with reduced nitric oxide scavenging as a blood substitute for resuscitation

Abstract Body: Background: Hemorrhagic shock remains a leading cause of preventable death. No artificial oxygen carrier based on hemoglobin or hemoproteins has been approved in the US as an alternative to donated blood. A major challenge for the hemoprotein oxygen carrier is the vasoconstrictive effects due to the nitric oxide (NO) scavenging. We have engineered a modified Regulator of Carbon Monoxide Metabolism (RcoM) heme-containing protein which shows no vasoconstrictive effects. We aim to validate the oxygen binding, NO dioxygenation rate, stability, and resuscitative effects of RcoM.
Hypothesis: We hypothesize that RcoM is well tolerated and can behave as an artificial oxygen carrier due to ideal oxygen binding rate, low autoxidation rate, slow NO dioxygenation rate, and high thermal/chemical stability.
Approach: We assessed biochemical features using UV-visible spectroscopy methods to determine the transitions between RcoM oxidation state and ligand binding and dissociation. We performed measures of oxygen binding and autoxidation. We carried out competition experiments in which equimolar amounts of RcoM and Hb were exposed to NO to measure NO deoxygenation rate. To assess oxygen carrier capabilities of Rcom, we used a murine model of traumatic, hemorrhagic shock utilizing anesthetized mice with a 2cm abdominal incision and left femoral artery and vein catheterization. Hemorrhage was induced by a 30-minute controlled bleeding to a target blood pressure of 25 to 40 mmHg, shock was maintained for 30 minutes, then infusion by lactated Ringer (LR) solution, 2mM stroma-free Hb, or 2mM RcoM at volume equal to removed blood and monitored for 30 minutes. Mean arterial pressure post resuscitation were compared to assess the tolerance and hemodynamics effects.
Results: RcoM displays appropriate oxygen binding capacity and has an NO deoxygenation rate ten-fold lower than Hb. In the murine hemorrhagic model, there was no difference for the baseline MAP or in blood removed during the bleeding phase. Post-resuscitation MAP was significantly higher for RcoM (67.0 ± 6.3 mmHg) and Hb (60.4 ± 16.0 mmHg) compared to LR (25.9 ± 21.4 mmHg, p = 0.0029). There was no difference between Rcom and Hb in the post-resuscitation MAP (p = 0.8573).
Conclusion: This study demonstrates that resuscitation with RcoM supports the blood pressure in a murine traumatic hemorrhagic shock model, suggesting its potential application as a non-globin artificial oxygen carrier for hemorrhagic shock.
  • Xu, Qinzi  ( University of Maryland , Baltimore , Maryland , United States )
  • Rochon, Elizabeth  ( University of Maryland , Baltimore , Maryland , United States )
  • Bocian, Kaitlin  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Huang, Xue  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Poropatich, Ronald  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Gladwin, Mark  ( University of Maryland , Baltimore , Maryland , United States )
  • Tejero, Jesus  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Rose, Jason  ( University of Maryland , Baltimore , Maryland , United States )
  • Rodriguez, Deborah  ( University of Maryland , Baltimore , Maryland , United States )
  • Hwang, Hyon  ( University of Maryland , Baltimore , Maryland , United States )
  • Turner, Bryan  ( University of Maryland , Baltimore , Maryland , United States )
  • Hunt, Thomas  ( University of Maryland , Baltimore , Maryland , United States )
  • Dent, Matthew  ( Wayne State University , Detroit , Michigan , United States )
  • Demartino, Anthony  ( University of Maryland , Baltimore , Maryland , United States )
  • Abdelghany, Youmna  ( University of Maryland , Baltimore , Maryland , United States )
  • Chen, Xiukai  ( University of Pittsburgh , Pittsburgh , Pennsylvania , United States )
  • Author Disclosures:
    Qinzi Xu: No Answer | Elizabeth Rochon: DO NOT have relevant financial relationships | Kaitlin Bocian: No Answer | Xue Huang: No Answer | Ronald Poropatich: No Answer | Mark Gladwin: No Answer | Jesus Tejero: No Answer | Jason Rose: DO have relevant financial relationships ; Executive Role:Globin Solutions:Active (exists now) ; Ownership Interest:Omnibus Medical Devices:Active (exists now) ; Research Funding (PI or named investigator):CareDx:Active (exists now) ; Research Funding (PI or named investigator):Globin Solutions:Active (exists now) ; Ownership Interest:Globin Solutions:Active (exists now) ; Royalties/Patent Beneficiary:Globin Solutions:Active (exists now) | Deborah Rodriguez: No Answer | Hyon Hwang: DO NOT have relevant financial relationships | Bryan Turner: No Answer | Thomas Hunt: No Answer | Matthew Dent: DO have relevant financial relationships ; Royalties/Patent Beneficiary:Globin Solutions, Inc.:Active (exists now) | Anthony DeMartino: No Answer | Youmna Abdelghany: No Answer | Xiukai Chen: No Answer
Meeting Info:

Resuscitation Science Symposium 2025

2025

New Orleans, Louisiana

Session Info:

Translational

Sunday, 11/09/2025 , 01:30PM - 03:00PM

ReSS25 Poster Session and Reception

More abstracts on this topic:
Association between Pressure-Adjusted Heart Rate and Mortality in Cardiogenic Shock

Ginder Curtis, Jentzer Jacob, Guo Jianping, Van Diepen Sean, Katz Jason, Morrow David, Berg David

A Novel CRISPR based Epigenetic Silencer Potently, Durably, and Safely Reduces LDLc in Non-Human Primates at Therapeutically Relevant Doses

Duncan-lewis Christopher, Narsineni Lokesh, Karmarkar Maitreyee, Li Yuexuan, Krupa Oleh, Bucher Simon, Sharma Neel, Chang Han, Schulwach Keith, Ripley-phipps Sterling, Tran Vanessa, Fernandes Jason, Goh Natalie, Deiter Fred, Reimer Kirsten, Mrak Anna, Eggers Michelle, Sze Christie, Mirotsou Maria, Oresic Bender Kristina, Bardai Farah, Denny Sarah, Charles Emeric, Khakoo Aarif, Oakes Benjamin, Keller Steven, Alcantara-lee Raniel, Santamaria Carlos, Bale Shyam Sundhar, Kozy Heather, Corbo Lana

More abstracts from these authors:
Evaluation of a Novel Oxygen Carrier for Resuscitation in Hemorrhagic Shock Model Using a Target Mutation of Recombinant Heme-Protein

Lawrence Joshua, Huang Xue, Chen Xiukai, Poropatich Ronald, Gladwin Mark, Rose Jason, Abdelghany Youmna, Gandhi Alay, Tejero Jesus, Demartino Anthony, Dent Matthew, Xu Qinzi, Hwang Hyon, Bocian Kaitlin

In vivo conversion of ferric heme to NO-ferroheme has vasodilatory and anti-inflammatory effects

Rochon Elizabeth, Demartino Anthony, Liu Ruya, Xu Qinzi, Kim-shapiro Daniel, Gladwin Mark

You have to be authorized to contact abstract author. Please, Login
Not Available